Trending Now
Technology, Legislation, the Supreme Court, and Your Cannabis Portfolio (YCBD, ECOX,...
There are two dimensions to the cannabis investment theme: the commodity market’s boom and bust cycle, and the legislative “arrow” of time.
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Finally, a Bitcoin Correction! What to do about it? (MSTR, OSTK,...
At long last, we may have a Bitcoin correction on our hands. The volatile cryptocurrency suffered a quick 10% price plunge over...
MAKE IT MODERN
LATEST REVIEWS
Gritstone bio Inc. (NASDAQ: GRTS) Expands Agreement With CEPI for self-amplifying...
Gritstone bio Inc. (NASDAQ: GRTS) has announced the expansion of its agreement with Coalition for Epidemic Preparedness Innovations, CEPI, supporting the creation of a...
MAKE IT MODERN
PERFORMANCE TRAINING
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Enter Into a Securities Purchase Agreement for a $25 Million...
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) has acquired a $25 million private placement with affiliates of an existing shareholder, RTW Investments, LP. This was accomplished through...
XORTX Therapeutics Inc ($XRTX): Pioneering New Treatments for Kidney Disease with a Precision-Medicine Approach
Today, XORTX Therapeutics Inc. (NASDAQ: XRTX) experienced a remarkable surge in its stock price, closing at $2.18 USD—a stunning 86.44% increase. The...
Evofem Biosciences Inc (NASDAQ:EVFM) Posts A Net Loss Of $52.7 Million In Q2 2020
Evofem Biosciences Inc (NASDAQ:EVFM) widened its net loss to $52.7 million in Q2 2020 compared to $35.5 million in Q1 2020. The company reduced...
GBT Technologies (GTCH) goal is to use its AI technology to overcome long range...
The global artificial intelligence market is on track to hit more than $554 billion in total revenue by 2024, according to market...
Ovid Therapeutics Inc. (NASDAQ:OVID) Announces Partnership For Development Of Rare Genetic Neurological Conditions Therapies
Ovid Therapeutics Inc. (NASDAQ:OVID) has announced a strategic research partnership with the Columbia University Irving Medical Centre researchers. The collaboration is meant for the...